Taras Koliadzhyn

Mr. Taras Koliadzhyn


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
NLNadiia Lehin
Nadiia Lehin
LGLyubov Grytsyk
Lyubov Grytsyk
Oleh KoshovyiOleh Koshovyi
Oleh Koshovyi
TKTaras Koliadzhyn
Taras Koliadzhyn
GRYTSYK ANDRIYGRYTSYK ANDRIY
GRYTSYK ANDRIY
Ain RaalAin Raal
Ain Raal
Sanicula europaea L. (Apiaceae), commonly known as European sanicle, has long been used in traditional medicine as a hemostatic agent, for accelerating wound healing, and for treating inflammatory and dermatological conditions. However, scientific evidence supporting these uses remains limited. Comprehensive phytochemical and pharmacological screening of extracts from the herb and rhizomes with roots of S. europaea holds promise, as aqueous and hydroethanolic extracts were obtained from its aerial and underground parts. Phytochemical analysis identified 16 phenolic compounds, including tannins, flavonoids (3.61–5.46% in the herb extracts; 0.13–0.21% in the rhizome-root extracts), hydroxycinnamic acids, and coumarin. The total phenolic content in the extracts ranged from 11.08% to 15.02%. Rosmarinic acid was the most abundant among the hydroxycinnamic acids. Quercetin and apigenin emerged as the leading flavonoids, and epicatechin gallate and gallocatechin were identified as the predominant tannin-related compounds. All tested extracts demonstrated anti-inflammatory activity in a formalin-induced paw oedema model. Hemostatic properties were assessed using the Duke bleeding time method, and the herb extracts significantly reduced bleeding time. The use of herb extracts also accelerated wound healing. Both herb and rhizome-root extracts exhibited inhibitory effects against P. aeruginosa, E. coli, P. vulgaris, S. aureus, and S. epidermidis in the agar diffusion method with paper discs. Based on the results of pharmacological screening, herb extracts of S. europaea demonstrated pronounced hemostatic, wound-healing, anti-inflammatory, and antimicrobial activities. Future studies should focus on expanding the experimental model and conducting clinical trials to assess safety, optimal dosage, and long-term efficacy.

4 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
NLNadiia Lehin
Nadiia Lehin
LGLyubov Grytsyk
Lyubov Grytsyk
Oleh KoshovyiOleh Koshovyi
Oleh Koshovyi
TKTaras Koliadzhyn
Taras Koliadzhyn
GRYTSYK ANDRIYGRYTSYK ANDRIY
GRYTSYK ANDRIY
Ain RaalAin Raal
Ain Raal
Sanicula europaea L. (Apiaceae), commonly known as European sanicle, has been long used in traditional medicine as a hemostatic agent, for accelerating wound healing, and for treating inflammatory and dermatological conditions. However, scientific evidence supporting these uses remains limited. Comprehensive phytochemical and pharmacological screening of extracts from the herb and rhizomes with roots of S. europaea holds promise, as aqueous and hydroethanolic extracts were obtained from its aerial and underground parts. Phytochemical analysis identified 16 phenolic compounds, including tannins, flavonoids, hydroxycinnamic acids, and coumarin. All tested extracts (100 mg/kg) demonstrated anti-inflammatory activity in a formalin-induced paw oedema model. Hemostatic properties were assessed using the Duke bleeding time method. Application of herb extracts reduced bleeding time by 49.56% and 48.29% compared to the control group, and by 34.37% and 32.72% relative to the reference drug. The use of herb extracts accelerated wound healing by 5.34 and 4.84 days compared to the control group, and by 1.5 and 1.0 days relative to the reference drug. Rhizome-root extracts shortened the healing process by 2.83 and 2.01 days compared to the control group, although healing occurred later than with the reference drug. Both herb and rhizome-root extracts exhibited inhibitory effects against rod-shaped and coccoid bacterial strains. Based on the results of pharmacological screening, herb extracts of S. europaea demonstrated pronounced hemostatic, wound-healing, anti-inflammatory, and antimicrobial activities.

2 January 2025 in Art of Medicine
Verified
Journal Article
Open access
PDF file
GSGalyna Starchenko
Galyna Starchenko
OSO. A. Struk
O. A. Struk
TKTaras Koliadzhyn
Taras Koliadzhyn
The aim of the work was to analyze the use of over-the-counter antipyretic drugs in young children. Methods and materials. Marketing, analytical, comparative analysis and generalization of information were chosen as research methods. The study of the analysis of the needs of fever patients in the improvement of pharmaceutical care was conducted based on three pharmacies of the Podorozhnyk pharmacy chain, which were in the city of Ivano-Frankivsk. We conducted sociological research using questionnaires. The survey was conducted from October 1 to 31, 2023. To ensure representativeness, according to the calculations, 50 respondents (visitors of pharmacies) were involved in the survey, who approached the pharmacy employee with the aim of purchasing an antipyretic drug for a younger child. The results of the analysis were processed using computer programs. The results. As of November 2023, the market of Ukraine is dominated by Ukrainian-made medical devices (66.7%). Among the dosage forms, tablets prevail - a total of 41 names and capsules (36 names), the least oral solutions and solutions for injections - 1 name each. Taking into account that the greater number of drugs refers to over-the-counter drugs, an important aspect of responsible self-medication by the patient and pharmaceutical care by the pharmacist is the clinical and pharmaceutical characteristics of the medicinal product in view of the API or its combination, its dose, dosage form, possibility and features application in separate groups of patients, in particular children, was the study and analysis of instructions for the medical use of drugs regarding the possibility of taking these drugs in children. According to the analysis of the instructions for pharmaceuticals, it was found that 28% of drugs are allowed for use in children from birth to 1 year, from 1 year - 2.29%, from 3 years - 0.7%, from 5 years - 6.8%, from 6 years - 35.6%, from 10 years - 0.7%, from 12 years - 12.9%, more than 7 kg - 4.6%, more than 20 kg - 3.1%, more than 33 kg - 3.79%, as prescribed by a doctor taking into account the benefits/risks - 1.5%. To ensure representativeness, according to the calculations, 50 visitors to the pharmacy (representatives of the child) who came to the pharmacy to purchase an antipyretic drug for the treatment of a child's fever were involved in the survey. Conclusions. The conducted clinical and pharmaceutical analysis showed that the treatment of hyperthermia in children must be approached very carefully, because the assortment of over-the-counter drugs in Ukraine is large, there is a synonymy of the names of drugs of individual companies, which contain different compositions of active substances of different concentrations, which are indicated for use in individual groups of patients. Considering that many pharmaceuticals are over the counter, an important aspect is the responsible attitude of the pharmaceutical worker to inform and warn the buyer of the pharmacy, as well as responsible self-medication on the part of the patient. The effectiveness of antipyretic therapy will be higher when the pediatrician works together with the child's parents to improve medical literacy. From an ethical and deontological point of view, only close contact between the pediatrician and the patients' parents will allow to effectively eliminate febrile syndrome and prevent its dangerous and sometimes fatal consequences.